Who Exports Cetuximab from India — 43 Suppliers Behind a $839.4K Market
India's cetuximab export market is supplied by 43 active exporters who collectively shipped $839.4K across 115 shipments. VAMA LIFECARE PRIVATE LIMITED leads with a 11.4% market share, followed by MILES INTERNATIONAL and MATSUN EXPORTS. The top 5 suppliers together control 30.8% of total export value, reflecting a moderately competitive market structure.
Top Cetuximab Exporters from India — Ranked by Export Value
VAMA LIFECARE PRIVATE LIMITED is the leading cetuximab exporter from India, holding a 11.4% share of the $839.4K market across 115 shipments from 43 exporters. The top 5 suppliers — VAMA LIFECARE PRIVATE LIMITED, MILES INTERNATIONAL, MATSUN EXPORTS, SPR ONCOCARE PRIVATE LIMITED, NU HOSPITALS PRIVATE LIMITED — collectively control 30.8% of total export value, indicating a competitive market. Individual shares are: VAMA LIFECARE PRIVATE LIMITED (11.4%), MILES INTERNATIONAL (6.1%), MATSUN EXPORTS (4.6%), SPR ONCOCARE PRIVATE LIMITED (4.5%), NU HOSPITALS PRIVATE LIMITED (4.1%).
Top Cetuximab Exporters from India
Ranked by export value · 43 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | VAMA LIFECARE PRIVATE LIMITED ERBITUX CETUXIMAB 100 MG INJ 20MLHARMLESS MEDICINE FOR HUMAN CONSUMPTION CETUXIMAB 100 MLRECOMBINANT CETUXIMAB DS 5 GRAMS | $95.8K | 2 | 11.4% |
| 2 | MILES INTERNATIONAL ERBITUX CETUXIMAB 100 MG INJ 20ML | $51.5K | 2 | 6.1% |
| 3 | MATSUN EXPORTS HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USEHARMLESS MEDICINE FOR HUMAN CONSUMPTIONCETUXA 100 MG | $38.8K | 1 | 4.6% |
| 4 | SPR ONCOCARE PRIVATE LIMITED CETUXIMAB LUPIN BATCH 1242411A EXP JULY2026HARMLESS MEDICINE FOR HUMAN CONSUMPTIONCETUXIMAB 5MG | $37.8K | 1 | 4.5% |
| 5 | NU HOSPITALS PRIVATE LIMITED CETUXIMAB - INJECTIONS - 100MG - LUPITUXCETUXIMAB - INJECTIONS - 100MG - ERBITUX | $34.5K | 1 | 4.1% |
| 6 | BRINTON PHARMACEUTICALS LIMITED | $13.3K | 1 | 1.6% |
| 7 | VEA IMPEX I PRIVATE LIMITED | $13.0K | 2 | 1.6% |
| 8 | VEA IMPEX (I) PRIVATE LIMITED | $9.5K | 2 | 1.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Cetuximab exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| VAMA LIFECARE PRIVATE LIMITED | Not Listed | Yes | No | Not verified | Vama Lifecare is a fully integrated pharmaceutical manufacturer and exporter wit |
| VEA IMPEX (I) PRIVATE LIMITED | Not Listed | No | No | Not verified | VEA Impex is a pharmaceutical exporter; specific GMP certifications are not list |
TransData Nexus reviewed the regulatory standing of 2 leading Cetuximab exporters from India. 0 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Cetuximab sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Pharma City of India," contributes approximately 40% of the country's bulk drug production. The city hosts over 2,000 pharmaceutical companies, including major players like Dr. Reddy's Laboratories, Aurobindo Pharma, and Natco Pharma. The establishment of Genome Valley, a premier biotech cluster, has further solidified Hyderabad's position as a global hub for pharmaceutical manufacturing and research.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a significant center for pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports. Vadodara is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907. The region's robust infrastructure and skilled workforce make it a key player in the pharmaceutical sector.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to various international markets. The region hosts numerous pharmaceutical companies and benefits from well-established logistics and transportation networks, enhancing its role in global pharmaceutical trade.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing hub, primarily due to favorable tax incentives offered by the government. This zone attracts numerous pharmaceutical companies seeking cost-effective production facilities, contributing significantly to India's pharmaceutical output.
5Sourcing Recommendations
- Leverage Hyderabad's Bulk Drug Production: Utilize Hyderabad's extensive bulk drug manufacturing capabilities for sourcing active pharmaceutical ingredients (APIs) essential for Cetuximab production.
- Engage with Gujarat's Formulation Experts: Collaborate with companies in the Ahmedabad-Vadodara corridor for their expertise in pharmaceutical formulations, ensuring high-quality finished products.
- Utilize Mumbai's Export Infrastructure: Take advantage of Mumbai's strategic location and established export infrastructure to facilitate efficient international distribution of Cetuximab.
- Consider Cost Benefits in Baddi-Nalagarh: Explore manufacturing opportunities in the Baddi-Nalagarh region to benefit from tax incentives and cost-effective production facilities.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Cetuximab exporters from India
VAMA LIFECARE PRIVATE LIMITED — Vama Lifecare partners with Tecno Farma S.A. for distribution in Panama
Vama Lifecare Private Limited entered into a distribution agreement with Tecno Farma S.A., a Panama-based importer, to expand its pharmaceutical product reach in the Central American market. - IMPACT: This collaboration is expected to enhance Vama Lifecare's export capabilities, potentially increasing Cetuximab shipments to Panama.
Impact: This collaboration is expected to enhance Vama Lifecare's export capabilities, potentially increasing Cetuximab shipments to Panama.
Common Questions — Cetuximab Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which cetuximab supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, VAMA LIFECARE PRIVATE LIMITED leads with 4 recorded shipments worth $95.8K. MILES INTERNATIONAL (12 shipments) and MATSUN EXPORTS (10 shipments) are also established high-volume exporters.
Q How many cetuximab manufacturers are there in India?
India has 43 active cetuximab exporters with a combined export market of $839.4K across 115 shipments to 30 countries. The top 5 suppliers hold 30.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for cetuximab from India?
Average FOB unit price: $371.57 per unit, ranging from $21.32 to $2750.00. Average shipment value: $7.3K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 43 verified Indian exporters of Cetuximab ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 115 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 30 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
115 Verified Shipments
43 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists